Literature DB >> 28212843

Natural extranuclear androgen receptor ligands as endocrine disruptors of cancer cell growth.

Marilena Kampa1, George Notas2, Elias Castanas2.   

Abstract

Even though the term endocrine disruption primarily designates environmental chemicals that can interfere with the action of hormones, in recent years it has been extended to include also plant derived compounds that can reach the human body, naturally, or have been identified and studied as alternative pharmaceutical agents. In fact, for a large number of them, their antihormonal action was appreciated by different traditional herbal medicines. In the present review we report the majority of the plant derived compounds that exhibit an antiandrogenic effect and the known mechanisms of action. These include a disruption at testosterone production level and at the classical androgen receptor triggered pathways, including membrane initiated ones. Finally, for the first time we describe the possible involvement of alternative cell membrane androgen receptor systems and the lipid signaling disruption by natural androgen, providing hints about a novel class of therapeutic involvement of androgens.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Androgen disruption; Androgen receptor; Cancer; Extranuclear actions; OXER1

Mesh:

Substances:

Year:  2017        PMID: 28212843     DOI: 10.1016/j.mce.2017.02.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  4 in total

1.  Prenatal low-dose DEHP exposure induces metabolic adaptation and obesity: Role of hepatic thiamine metabolism.

Authors:  Yun Fan; Yufeng Qin; Minjian Chen; Xiuzhu Li; Ruohan Wang; Zhenyao Huang; Qiaoqiao Xu; Mingming Yu; Yan Zhang; Xiumei Han; Guizhen Du; Yankai Xia; Xinru Wang; Chuncheng Lu
Journal:  J Hazard Mater       Date:  2019-10-28       Impact factor: 10.588

2.  Preparation of polypyrrole/nanosilica composite for solid-phase microextraction of bisphenol and phthalates migrated from containers to eye drops and injection solutions.

Authors:  Mehdi Ansari Dogaheh; Mansoureh Behzadi
Journal:  J Pharm Anal       Date:  2019-03-15

3.  OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression.

Authors:  Mirco Masi; Enrico Garattini; Marco Bolis; Daniele Di Marino; Luisa Maraccani; Elena Morelli; Ambra A Grolla; Francesca Fagiani; Emanuela Corsini; Cristina Travelli; Stefano Govoni; Marco Racchi; Erica Buoso
Journal:  Oncogenesis       Date:  2020-12-11       Impact factor: 7.485

Review 4.  Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers.

Authors:  Mirco Masi; Marco Racchi; Cristina Travelli; Emanuela Corsini; Erica Buoso
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.